Quantitative HER2 and p95HER2 levels in primary breast cancers and matched brain metastases

BACKGROUND: Patients with advanced breast cancer positive for human epidermal growth factor receptor 2 (HER2) are at high risk for brain metastasis (BM). The prevalence and significance of expression of HER2 and its truncated form p95HER2 (p95) in BM is unknown. METHODS: Seventy-five pairs of formal...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuro Oncol
Autori principali: Duchnowska, Renata, Sperinde, Jeff, Chenna, Ahmed, Huang, Weidong, Weidler, Jodi M., Winslow, John, Haddad, Mojgan, Paquet, Agnes, Lie, Yolanda, Trojanowski, Tomasz, Mandat, Tomasz, Kowalczyk, Anna, Czartoryska-Arłukowicz, Bogumiła, Radecka, Barbara, Jarosz, Bożena, Staszkiewicz, Rafal, Kalinka-Warzocha, Ewa, Chudzik, Małgorzata, Biernat, Wojciech, Jassem, Jacek
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2015
Soggetti:
Basic and Translational Investigations
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4588754/
https://ncbi.nlm.nih.gov/pubmed/25681308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nov012
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi